Skip to main content
Clinical Trials/NCT02288923
NCT02288923CompletedNot Applicable

A Randomised, Observer Blinded, Controlled Trial Of Femoral Nerve Block Versus Local Infiltration Analgesia for Post Operative Analgesia Following Total Knee Arthroplasty

Royal Devon and Exeter NHS Foundation Trust1 site in 1 country199 target enrollmentStarted: March 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
199
Locations
1
Primary Endpoint
Morphine consumption in first post-operative 72 hours

Study Overview

Brief Summary

Pain after a knee replacement can impair recovery and use of the new knee. Having an injection to numb the femoral nerve is known to give good pain relief after the operation but may lead to slower mobilisation as it also prevents the patient from moving the knee. Recent studies have shown that infiltration of local anaesthetic (LIA) within the new knee joint may also give good pain relief. The null hypothesis is that there is no difference in primary or secondary outcome measures between femoral nerve block and LIA, as anaesthetic techniques for knee replacement.

Detailed Description

Knee pain and stiffness is a common problem which can sometimes be improved by inserting a replacement knee joint. An anaesthetist is a doctor who specialises in looking after patients undergoing surgery, and there are a variety of different anaesthetics which can be used for knee replacement surgery. These include general anaesthesia (going to sleep), and spinal or epidural anaesthesia (where pain killers are injected into the back, resulting in temporarily numb legs). Pain killers can also be injected around the nerves which supply the leg, or around the site of the operation itself, combined with general or spinal anaesthesia if required.

Over the years, multiple different combinations of these techniques have been tried. All have advantages and disadvantages. Generally, those which completely numb the leg after the operation often cause weakness which interferes with movement. Although the patient will have no pain, getting up and around with the physiotherapist is crucial and the weakness can delay recovery. However, excessive pain can also interfere with movement. There is therefore a balance to be struck between pain and weakness, and the choice of anaesthetic technique is key.

Researchers previously conducted a study at the Royal Devon and Exeter Hospital which compared the effects of two techniques; the use of diamorphine in a spinal injection, and the injection of pain killer around a nerve supplying the leg (femoral nerve block, FNB). Whilst the research showed that FNB gave better pain relief, there are still concerns that it causes weakness which may interfere with movement. A newer technique has evolved over recent years in which pain killer is injected directly around the knee during the operation. This is known as local infiltration analgesia (LIA) and the potential advantages are that it is simple, safe and does not cause leg weakness.

If research shows that LIA provides adequate pain relief without weakness, it may be a better option to use routinely, rather than FNB. The primary outcome measure is the amount of morphine used in the first 48 hours. The secondary outcome measures are the Total Pain Relief Score (TOTPAR), post operative pain scores, the ability to achieve set rehabilitation goals, readiness for discharge and qualitative data on patient recovery and satisfaction.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All adult patients presenting for primary knee arthroplasty under the care of the Exeter Knee Unit Consultants Messrs Toms, Eyres, Cox, Mandalia, Schrantz.

Exclusion Criteria

  • Total knee arthroplasty for trauma
  • Unicompartmental surgery
  • Bilateral surgery
  • Contra indication to spinal anaesthesia or peripheral nerve blocks (anticoagulation, hydrocephalus, raised intracranial pressure, peripheral neuropathy)
  • Allergy to local anaesthetics or morphine
  • Chronic pain:
  • Under active follow up by chronic pain team
  • Chronic strong opiate use (morphine, oxycodone, buprenorphine, pethidine, methadone). Codeine, dihydrocodeine and tramadol are not included
  • Other chronic pain medications (including gabapentin, pregabalin or amitriptyline)
  • Unable to adequately understand verbal explanations or written information given in English, or patients with special communication needs -

Arms & Interventions

Femoral nerve block

Active Comparator

Femoral nerve block with 20ml 0.375% Levobupivacaine

Intervention: Femoral nerve block (Procedure)

Femoral nerve block

Active Comparator

Femoral nerve block with 20ml 0.375% Levobupivacaine

Intervention: Sub arachnoid analgesia (Procedure)

Femoral nerve block

Active Comparator

Femoral nerve block with 20ml 0.375% Levobupivacaine

Intervention: Sedation or general anaesthesia (Procedure)

Femoral nerve block

Active Comparator

Femoral nerve block with 20ml 0.375% Levobupivacaine

Intervention: Pre-medication (Drug)

Femoral nerve block

Active Comparator

Femoral nerve block with 20ml 0.375% Levobupivacaine

Intervention: Intra-operative medication (Drug)

Femoral nerve block

Active Comparator

Femoral nerve block with 20ml 0.375% Levobupivacaine

Intervention: Post-operative analgesia - morphine (Drug)

Femoral nerve block

Active Comparator

Femoral nerve block with 20ml 0.375% Levobupivacaine

Intervention: Post-operative analgesia - ibuprofen and paracetamol (Drug)

Femoral nerve block

Active Comparator

Femoral nerve block with 20ml 0.375% Levobupivacaine

Intervention: Regular anti emetics (Drug)

Local Infiltration Analgesia

Active Comparator

Local infiltration of knee joint using 40ml of bupivacaine 0.25% with adrenaline 1:200 000, diluted to 150ml with saline 0.9%. This is then divided into thirds; 50ml into the posterior capsule before cementing, 50ml into the medial and lateral capsules and 50ml into subcutaneous tissues and in and around the vastus medialis and sartorius muscles (where it may block the saphenous nerve).

Intervention: Local Infiltration Analgesia (Procedure)

Local Infiltration Analgesia

Active Comparator

Local infiltration of knee joint using 40ml of bupivacaine 0.25% with adrenaline 1:200 000, diluted to 150ml with saline 0.9%. This is then divided into thirds; 50ml into the posterior capsule before cementing, 50ml into the medial and lateral capsules and 50ml into subcutaneous tissues and in and around the vastus medialis and sartorius muscles (where it may block the saphenous nerve).

Intervention: Sub arachnoid analgesia (Procedure)

Local Infiltration Analgesia

Active Comparator

Local infiltration of knee joint using 40ml of bupivacaine 0.25% with adrenaline 1:200 000, diluted to 150ml with saline 0.9%. This is then divided into thirds; 50ml into the posterior capsule before cementing, 50ml into the medial and lateral capsules and 50ml into subcutaneous tissues and in and around the vastus medialis and sartorius muscles (where it may block the saphenous nerve).

Intervention: Sedation or general anaesthesia (Procedure)

Local Infiltration Analgesia

Active Comparator

Local infiltration of knee joint using 40ml of bupivacaine 0.25% with adrenaline 1:200 000, diluted to 150ml with saline 0.9%. This is then divided into thirds; 50ml into the posterior capsule before cementing, 50ml into the medial and lateral capsules and 50ml into subcutaneous tissues and in and around the vastus medialis and sartorius muscles (where it may block the saphenous nerve).

Intervention: Pre-medication (Drug)

Local Infiltration Analgesia

Active Comparator

Local infiltration of knee joint using 40ml of bupivacaine 0.25% with adrenaline 1:200 000, diluted to 150ml with saline 0.9%. This is then divided into thirds; 50ml into the posterior capsule before cementing, 50ml into the medial and lateral capsules and 50ml into subcutaneous tissues and in and around the vastus medialis and sartorius muscles (where it may block the saphenous nerve).

Intervention: Intra-operative medication (Drug)

Local Infiltration Analgesia

Active Comparator

Local infiltration of knee joint using 40ml of bupivacaine 0.25% with adrenaline 1:200 000, diluted to 150ml with saline 0.9%. This is then divided into thirds; 50ml into the posterior capsule before cementing, 50ml into the medial and lateral capsules and 50ml into subcutaneous tissues and in and around the vastus medialis and sartorius muscles (where it may block the saphenous nerve).

Intervention: Post-operative analgesia - morphine (Drug)

Local Infiltration Analgesia

Active Comparator

Local infiltration of knee joint using 40ml of bupivacaine 0.25% with adrenaline 1:200 000, diluted to 150ml with saline 0.9%. This is then divided into thirds; 50ml into the posterior capsule before cementing, 50ml into the medial and lateral capsules and 50ml into subcutaneous tissues and in and around the vastus medialis and sartorius muscles (where it may block the saphenous nerve).

Intervention: Post-operative analgesia - ibuprofen and paracetamol (Drug)

Local Infiltration Analgesia

Active Comparator

Local infiltration of knee joint using 40ml of bupivacaine 0.25% with adrenaline 1:200 000, diluted to 150ml with saline 0.9%. This is then divided into thirds; 50ml into the posterior capsule before cementing, 50ml into the medial and lateral capsules and 50ml into subcutaneous tissues and in and around the vastus medialis and sartorius muscles (where it may block the saphenous nerve).

Intervention: Regular anti emetics (Drug)

Outcomes

Primary Outcomes

Morphine consumption in first post-operative 72 hours

Time Frame: 72 hours

The total amount of morphine consumed by the patient in the first 72 post-operative hours will be added up. If morphine has been given orally it will be counted as ⅓ the intravenous dose.

Secondary Outcomes

  • Total pain relief score(Post op days 1, 2 and 3)
  • Post operative pain scores(Day 0 - 3 post op)
  • Achievement of rehabilitation goals(1-4 days post operatively)
  • Readiness for discharge(Post operative day 2-10)
  • Patient satisfaction(2nd post-operative day)
  • Oxford Knee Score(Pre op and 6 weeks post operatively)
  • EuroQol 5 dimensions score(Pre op and 6 weeks post operatively)

Investigators

Sponsor
Royal Devon and Exeter NHS Foundation Trust
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Fiona Martin

Consultant Anaesthetist

Royal Devon and Exeter NHS Foundation Trust

Study Sites (1)

Loading locations...

Similar Trials